- Home
- IHRT vs TSHA Comparison
IHRT vs TSHA Comparison
Compare IHRT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IHRT | TSHA |
|---|---|---|
| Founded | 1974 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.5M | 1.8B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IHRT | TSHA |
|---|---|---|
| Price | $2.63 | $5.02 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $4.25 | ★ $11.63 |
| AVG Volume (30 Days) | 416.4K | ★ 1.9M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.19 | 5.56 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,864,991,000.00 | $9,773,000.00 |
| Revenue This Year | $9.96 | N/A |
| Revenue Next Year | N/A | $1,152.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.27 | ★ 17.28 |
| 52 Week Low | $2.45 | $2.72 |
| 52 Week High | $6.56 | $7.30 |
Technical Indicators
Market Signals| Indicator | IHRT | TSHA |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 32.48 |
| Support Level | $2.56 | $4.37 |
| Resistance Level | $2.90 | $5.07 |
| Average True Range (ATR) | 0.13 | 0.24 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 23.19 | 11.68 |
Price Performance
Historical ComparisonAbout IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.